Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Teeft.i » - entrée « Viral replication »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Viral replicase < Viral replication < Viral replication cycle  Facettes :

List of bibliographic references indexed by Viral replication

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000B31 (2012) Glendie Marcelin [États-Unis] ; Matthew R. Sandbulte [États-Unis] ; Richard J. Webby [États-Unis]Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
000D46 (2011) Karen Ka Yin Wong [Australie] ; Rowena A. Bull [Australie] ; Steve Rockman [Australie] ; Gillian Scott [Australie] ; Sacha Stelzer-Braid [Australie] ; William Rawlinson [Australie]Correlation of polymerase replication fidelity with genetic evolution of influenza A/Fujian/411/02(H3N2) viruses
000F62 (2010) A. C. Marriott [Royaume-Uni] ; N. J. Dimmock [Royaume-Uni]Defective interfering viruses and their potential as antiviral agents
001612 (2005) Penelope Ward [Royaume-Uni] ; Ian Small [Royaume-Uni] ; James Smith [Suisse] ; Pia Suter [Suisse] ; Regina Dutkowski [États-Unis]Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
001676 (2004) Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
001774 (2002) Gabriele Neumann [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon]Generation of influenza A virus from cloned cDNAs — historical perspective and outlook for the new millenium
001856 (2001) Maria C. Zambon [Royaume-Uni]The pathogenesis of influenza in humans
001913 (2000) D. L Suarez [États-Unis] ; S. Schultz-Cherry [États-Unis]Immunology of avian influenza virus: a review
001927 (2000) Irina A. Leneva [États-Unis] ; Noel Roberts [Royaume-Uni] ; Elena A. Govorkova [États-Unis] ; Olga G. Goloubeva [États-Unis] ; Robert G. Webster [États-Unis]The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
001940 (2000) J. M. Katz [États-Unis] ; X. Lu ; A. M. Frace [États-Unis] ; T. Morken [États-Unis] ; S. R. Zaki [États-Unis] ; T. M. Tumpey [États-Unis]Pathogenesis of and immunity to avian influenza A H5 viruses
001942 (2000) Margaret Tisdale [Royaume-Uni]Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
001956 (2000) J. Yoshimoto [Japon] ; S. Yagi [Japon] ; J. Ono [Japon] ; K. Sugita [Japon] ; N. Hattori [Japon] ; T. Fujioka [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hashimoto [Japon]Development of Anti‐influenza Drugs: II. Improvement of Oral and Intranasal Absorption and the Anti‐influenza Activity of Stachyflin Derivatives
001963 (2000) Flor M. MunozAntiviral agents in the critically ill child
001A08 (1999) Hiroshi Kido [Japon] ; Yoshihito Beppu [Japon] ; Yasuhiro Imamura [Japon] ; Ye Chen [Japon] ; Meiko Murakami [Japon] ; Kumiko Oba [Japon] ; Takae Towatari [Japon]The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
001A46 (1998) John S. Oxford [Royaume-Uni] ; Robert Lambkin [Royaume-Uni]Targeting influenza virus neuraminidase—a new strategy for antiviral therapy
001B01 (1998) Jane E. Bailly [Canada] ; Earl G. Brown [Canada]Interference by a non-defective variant of influenza A virus is due to enhanced RNA synthesis and assembly
001B30 (1997) Richard L. HodinkaWHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE
001B80 (1997) Edwin D. Kilbourne [États-Unis]In pursuit of influenza: Fort monmouth to valhalla (and back)
001C72 (1996) Gary R. Burleson [États-Unis] ; Hervé Lebrec [États-Unis] ; Yung G. Yang [États-Unis] ; Joelle D. Ibanes [États-Unis] ; Kevin N. Pennington [États-Unis] ; Linda S. Birnbaum [États-Unis]Effect of 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) on Influenza Virus Host Resistance in Mice
001D09 (1995) David W. Kimberlin [États-Unis] ; Earl R. Kern [États-Unis] ; Robert W. Sidwell [États-Unis] ; Thomas W. North [États-Unis] ; Richard J. Whitley [États-Unis]Models of antiviral resistance
001D39 (1995) John Saunders [Royaume-Uni] ; Janet M. Cameron [Royaume-Uni]Recent developments in the design of antiviral agents

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Viral replication" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Viral replication" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Viral replication
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021